Company / Cash per Share
Olema Pharmaceuticals, Inc. Cash per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$2.37
FY2024
5-year range
$0.35 / $48.22
FY2020-FY2024
Trend
+56.7%
vs FY2023
Sector context
#89 of 205
Health Care
What the data says
At $2.37, Olema Pharmaceuticals, Inc.'s cash per share ranks #89 of 205 in the Health Care sector. Cash per Share has increased for 3 consecutive years, from $0.35 in FY2021 to $2.37 in FY2024.
Based on SEC 10-K filings.
2.37 in FY2024 with a 3-year CAGR of +89.4%.
Improved from $0.59 to $2.37 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +89.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#89 of 205 in Health CareTop 43% of 205This company $2.37 Sector average $72.93
▼
-96.7% below sector average
Key checks
Key Insights
- Olema Pharmaceuticals, Inc.'s cash per share has grown for 3 consecutive years.
- In FY2024, cash per share increased 56.7% year-over-year.
- Ranks #89 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.74 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $2.37 | +56.7% |
| FY2023 | $1.51 | +155.6% |
| FY2022 | $0.59 | +69.6% |
| FY2021 | $0.35 | -99.3% |
| FY2020 | $48.22 | - |
| FY2019 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026